Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

US Patent 11608344 · Granted Mar 21, 2023

Estimated economic value: $375,298,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025